Platelet-Rich Plasma for Erectile Dysfunction After Radical Prostatectomy
Key facts
- Who runs it
- Herlev and Gentofte Hospital
- Where
- Denmark1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 10 Nov 2026
- Expected to end
- Nov 2029
- Type of study
- Interventional, 2 groups
- Treatments tested
- Autologous Platelet Rich Plasma
- saline solution (placebo)
- Record updated
- 6 November 2026
Who can take part
- Age
- 40 years to 75 years
- Sex
- Men only
- Healthy volunteers
- Cannot take part
Show the full registry criteria (15)Hide the full registry criteria
Who can take part
- Age 40-75 years
- Underwent unilateral or bilateral nerve-sparing radical prostatectomy between 1 and 3 years prior to the study
- Good erectile function prior to surgery (IIEF-EF score ≥ 22)
- Erectile dysfunction at inclusion with an IIEF-EF score < 22 without aids
- Acceptance of a pause in other treatments for erectile dysfunction from 4 weeks before baseline (wash-out) until the 1-month follow-up after the last injection
- In a stable relationship lasting at least 6 months with a desire for sexual activity
- Able to understand and accept the study protocol
Who cannot take part
- Other surgery or radiation therapy in the pelvic region
- Use of anti-androgen medication
- Peyronie's disease and/or previous episodes of priapism
- Known psychiatric, neurological and/or endocrinological disease requiring medication (including hypogonadism with total testosterone <12 nmol/l)
- Clinical or biochemical recurrence of prostate cancer
- Severe cardiac disease in the form of unstable angina, NYHA class >II heart failure, uncontrolled arrhythmia, or severe symptomatic and/or significant valvular disease
- Severe urinary incontinence preventing sexual activity (assessed by a physician at inclusion)
- Excessive alcohol consumption (more than 21 units per week)
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Sex
- Erectile dysfunction
This trial is currently available in Denmark.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study will test whether injections of platelet-rich plasma (PRP) can improve erectile function in men with persistent erectile dysfunction (ED) at least 12 months after nerve-sparing radical prostatectomy for prostate cancer. Participants will be randomly assigned to receive either two PRP injections or two saline (placebo) injections into the penis, administered one month apart in a double-blind fashion. Erectile function will be assessed using the International Index of Erectile Function (IIEF) questionnaire at baseline and at 1, 3, 6, and 12 months after the last injection. The primary objective is to determine whether PRP improves the erectile function domain of the IIEF more than saline at one month after the last injection
The 2 groups in the trial
- Platelet Rich Plasma (PRP)Treatment being tested
A volume of 5 mL PRP will be administered in corpus cavernosum on two occasions, with a 1-month interval between injections
Treatment: Autologous Platelet Rich Plasma
- Saline Solution (Placebo)Other group
A volume of 5 mL saline solution will be administered in corpus cavernosum on two occasions, with a 1-month interval between injections.
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 3 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Treatment of Erectile Dysfunction After Radical Prostatectomy With Platelet-Rich Plasma Injections: a Randomized Controlled Trial
- Criteria questions
- Built from NCT07863388, who can take part
- Record updated
- 6 November 2026